Real-time enrollment status for this prostatic neoplasms clinical trial
Current Status
Recruiting
Checked: October 9, 2026 at 10:57 PM UTC
| NCT Number | NCT07832292 |
| Recruiting Status | Recruiting |
| Condition | Prostatic Neoplasms |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 9, 2026: Clinical trial NCT07832292 is currently recruiting participants. This phase2 study for prostatic neoplasms is actively seeking new participants at 4 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07832292 is actively recruiting participants as of October 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07832292 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.